Annual CFF
$52.69 M
+$23.63 M+81.35%
31 December 2023
Summary:
T2 Biosystems annual cash flow from financing activities is currently $52.69 million, with the most recent change of +$23.63 million (+81.35%) on 31 December 2023. During the last 3 years, it has risen by +$32.15 million (+156.58%). TTOO annual CFF is now -38.45% below its all-time high of $85.61 million, reached on 31 December 2020.TTOO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$4.09 M
-$3.19 M-43.82%
30 September 2024
Summary:
T2 Biosystems quarterly cash flow from financing activities is currently $4.09 million, with the most recent change of -$3.19 million (-43.82%) on 30 September 2024. Over the past year, it has increased by +$3.28 million (+403.57%). TTOO quarterly CFF is now -93.96% below its all-time high of $67.75 million, reached on 30 September 2014.TTOO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$14.38 M
-$17.55 M-54.96%
30 September 2024
Summary:
T2 Biosystems TTM cash flow from financing activities is currently $14.38 million, with the most recent change of -$17.55 million (-54.96%) on 30 September 2024. Over the past year, it has dropped by -$38.31 million (-72.70%). TTOO TTM CFF is now -84.10% below its all-time high of $90.46 million, reached on 30 September 2020.TTOO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTOO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +403.6% | -72.7% |
| 3 y3 years | +156.6% | +1610.9% | -30.0% |
| 5 y5 years | +729.7% | -17.6% | +126.5% |
TTOO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +156.6% | -82.4% | +1610.9% | -73.5% | +167.0% |
| 5 y | 5 years | -38.5% | +729.7% | -89.8% | >+9999.0% | -84.1% | +167.0% |
| alltime | all time | -38.5% | +1057.7% | -94.0% | +447.4% | -84.1% | +705.0% |
T2 Biosystems Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.09 M(-43.8%) | $14.38 M(-55.0%) |
| June 2024 | - | $7.28 M(+230.6%) | $31.93 M(-25.8%) |
| Mar 2024 | - | $2.20 M(+171.2%) | $43.04 M(-18.3%) |
| Dec 2023 | $52.69 M(+81.3%) | $812.00 K(-96.2%) | $52.69 M(+0.1%) |
| Sept 2023 | - | $21.64 M(+17.7%) | $52.62 M(-2.8%) |
| June 2023 | - | $18.39 M(+55.2%) | $54.17 M(+36.4%) |
| Mar 2023 | - | $11.85 M(+1484.0%) | $39.70 M(+36.6%) |
| Dec 2022 | $29.05 M(+41.5%) | $748.00 K(-96.8%) | $29.05 M(+1.8%) |
| Sept 2022 | - | $23.18 M(+491.3%) | $28.55 M(+430.0%) |
| June 2022 | - | $3.92 M(+226.2%) | $5.39 M(-75.2%) |
| Mar 2022 | - | $1.20 M(+402.9%) | $21.68 M(+5.6%) |
| Dec 2021 | $20.54 M(-76.0%) | $239.00 K(+895.8%) | $20.54 M(+0.6%) |
| Sept 2021 | - | $24.00 K(-99.9%) | $20.41 M(-61.3%) |
| June 2021 | - | $20.22 M(>+9900.0%) | $52.78 M(+15.8%) |
| Mar 2021 | - | $53.00 K(-52.7%) | $45.56 M(-46.8%) |
| Dec 2020 | $85.61 M(+1248.1%) | $112.00 K(-99.7%) | $85.61 M(-5.4%) |
| Sept 2020 | - | $32.40 M(+149.2%) | $90.46 M(+51.6%) |
| June 2020 | - | $13.00 M(-67.6%) | $59.68 M(+27.5%) |
| Mar 2020 | - | $40.10 M(+707.6%) | $46.79 M(+636.9%) |
| Dec 2019 | $6.35 M(-87.2%) | $4.96 M(+207.1%) | $6.35 M(+390.0%) |
| Sept 2019 | - | $1.62 M(+1343.8%) | $1.30 M(-459.0%) |
| June 2019 | - | $112.00 K(-132.6%) | -$361.00 K(-100.7%) |
| Mar 2019 | - | -$344.00 K(+286.5%) | $49.66 M(+0.0%) |
| Dec 2018 | $49.66 M | -$89.00 K(+122.5%) | $49.66 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$40.00 K(-100.1%) | $49.60 M(-27.3%) |
| June 2018 | - | $50.13 M(<-9900.0%) | $68.20 M(+269.2%) |
| Mar 2018 | - | -$348.00 K(+138.4%) | $18.47 M(-0.2%) |
| Dec 2017 | $18.50 M(-64.2%) | -$146.00 K(-100.8%) | $18.50 M(-34.4%) |
| Sept 2017 | - | $18.56 M(+4459.7%) | $28.22 M(-40.4%) |
| June 2017 | - | $407.00 K(-229.6%) | $47.33 M(-8.3%) |
| Mar 2017 | - | -$314.00 K(-103.3%) | $51.59 M(-0.3%) |
| Dec 2016 | $51.76 M(+14.6%) | $9.57 M(-74.6%) | $51.76 M(-40.1%) |
| Sept 2016 | - | $37.67 M(+707.5%) | $86.42 M(+77.3%) |
| June 2016 | - | $4.67 M(-3230.9%) | $48.75 M(+9.0%) |
| Mar 2016 | - | -$149.00 K(-100.3%) | $44.72 M(-1.0%) |
| Dec 2015 | $45.17 M(-38.9%) | $44.24 M(<-9900.0%) | $45.17 M(+417.8%) |
| Sept 2015 | - | -$3000.00(-100.5%) | $8.72 M(-88.6%) |
| June 2015 | - | $636.00 K(+112.0%) | $76.48 M(+2.4%) |
| Mar 2015 | - | $300.00 K(-96.1%) | $74.67 M(+1.0%) |
| Dec 2014 | $73.92 M(+89.7%) | $7.79 M(-88.5%) | $73.92 M(+12.4%) |
| Sept 2014 | - | $67.75 M(-5856.3%) | $65.75 M(-2866.0%) |
| June 2014 | - | -$1.18 M(+163.9%) | -$2.38 M(+94.8%) |
| Mar 2014 | - | -$446.00 K(+17.4%) | -$1.22 M(-103.1%) |
| Dec 2013 | $38.98 M(+756.4%) | -$380.00 K(+1.6%) | $38.98 M(-1.0%) |
| Sept 2013 | - | -$374.00 K(+1770.0%) | $39.35 M(-0.9%) |
| June 2013 | - | -$20.00 K(-100.1%) | $39.73 M(-0.1%) |
| Mar 2013 | - | $39.75 M | $39.75 M |
| Dec 2012 | $4.55 M | - | - |
FAQ
- What is T2 Biosystems annual cash flow from financing activities?
- What is the all time high annual CFF for T2 Biosystems?
- What is T2 Biosystems quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for T2 Biosystems?
- What is T2 Biosystems quarterly CFF year-on-year change?
- What is T2 Biosystems TTM cash flow from financing activities?
- What is the all time high TTM CFF for T2 Biosystems?
- What is T2 Biosystems TTM CFF year-on-year change?
What is T2 Biosystems annual cash flow from financing activities?
The current annual CFF of TTOO is $52.69 M
What is the all time high annual CFF for T2 Biosystems?
T2 Biosystems all-time high annual cash flow from financing activities is $85.61 M
What is T2 Biosystems quarterly cash flow from financing activities?
The current quarterly CFF of TTOO is $4.09 M
What is the all time high quarterly CFF for T2 Biosystems?
T2 Biosystems all-time high quarterly cash flow from financing activities is $67.75 M
What is T2 Biosystems quarterly CFF year-on-year change?
Over the past year, TTOO quarterly cash flow from financing activities has changed by +$3.28 M (+403.57%)
What is T2 Biosystems TTM cash flow from financing activities?
The current TTM CFF of TTOO is $14.38 M
What is the all time high TTM CFF for T2 Biosystems?
T2 Biosystems all-time high TTM cash flow from financing activities is $90.46 M
What is T2 Biosystems TTM CFF year-on-year change?
Over the past year, TTOO TTM cash flow from financing activities has changed by -$38.31 M (-72.70%)